1 Jun 2020 11:16
UK TRADING UPDATE SUMMARY: Fuller Smith & Turner Gets GBP100 Million
UK TRADING UPDATE SUMMARY: Fuller Smith & Turner Gets GBP100 Million
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
MTFB.L Share News (MTFB)
MTFB Share
Price
MTFB Share
News
MTFB Share
Chat
MTFB Share
Trades
MTFB
Live RNS
MTFB Share
Charts
MTFB Broker
Ratings
MTFB Directors
Deals
MTFB Financial
Diary
MTFB
Fundamentals
MTFB Short
Positions
MTFB
Media
MTFB.L Information
- There is currently no data for MTFB
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.5 May 2020 10:58
Motif Bio Raises GBP650,000 To Strengthen Cash Position
Motif Bio Raises GBP650,000 To Strengthen Cash Position
Read more5 May 2020 09:17
Motif Bio raises ?0.65m as it hunts for reverse takeover opportunity
(Sharecast News) - Motif Bio, which has been reclassified as an AIM rule 15 cash shell, has raised a total of ?0.65m before expenses via a placing, it announced on Tuesday, through the issue of 162,500,000 ordinary shares with an institutional investor at a price of 0.4p each.
Read more4 May 2020 15:42
UK EXECUTIVE CHANGE SUMMARY: Scapa Healthcare, Industrial Heads Resign
UK EXECUTIVE CHANGE SUMMARY: Scapa Healthcare, Industrial Heads Resign
Read more14 Apr 2020 17:12
Motif Bio Notes Hike In Share Price, Still Waiting For Sale Of Assets
Motif Bio Notes Hike In Share Price, Still Waiting For Sale Of Assets
Read more19 Mar 2020 14:51
Motif Bio Still Seeks To Make Acquisition As Working Capital Dwindles
Motif Bio Still Seeks To Make Acquisition As Working Capital Dwindles
Read more18 Mar 2020 15:33
Motif Bio struggling to find reverse takeover opportunity
(Sharecast News) - Motif Bio updated the market on its corporate developments on Wednesday, having been reclassified as an AIM rule 15 cash shell.
Read more28 Jan 2020 11:31
Motif Bio And Hercules Amend Agreement To Facilitate Iclaprim Sale
Motif Bio And Hercules Amend Agreement To Facilitate Iclaprim Sale
Read more26 Nov 2019 18:15
Motif Bio To De-List From Nasdaq, Last Day Of Trading December 16
Motif Bio To De-List From Nasdaq, Last Day Of Trading December 16
Read more18 Nov 2019 13:50
Five Motif Bio Non-Executive Directors Leave As Part Of Restructuring
Five Motif Bio Non-Executive Directors Leave As Part Of Restructuring
Read more11 Nov 2019 09:52
Motif Bio Seals Clinical Research Firm Settlement Without Payments
Motif Bio Seals Clinical Research Firm Settlement Without Payments
Read more11 Nov 2019 09:40
Motif Bio reaches settlement with former clinical research organisation
(Sharecast News) - Motif Bio announced on Monday that its subsidiary Motif BioSciences has reached an agreement with its former clinical research organisation to settle all obligations without further payment.
Read more25 Oct 2019 17:34
Invesco Cuts Stake In Biopharmaceutifcal Firm Motif Bio To 8.4%
Invesco Cuts Stake In Biopharmaceutifcal Firm Motif Bio To 8.4%
Read more24 Oct 2019 16:05
Motif Bio announces US Army-funded evaluation of 'iclaprim'
(Sharecast News) - Clinical-stage biopharmaceutical company Motif Bio has signed an agreement with the Walter Reed Army Institute of Research (WRAIR) to conduct pre-clinical testing to evaluate novel combinations with 'iclaprim', to improve safety and efficacy administered by a novel enhanced aerosol technology, it announced on Thursday.
Read more24 Oct 2019 12:01
Motif Bio Teams Up With US Forces To Look Into Iclaprim Use
Motif Bio Teams Up With US Forces To Look Into Iclaprim Use
Read more